Thus, it is possible that under specific conditions where perforin cannot act like genetic deficiency (perforin KO mice or human type 2 FHL) or in cancer cells with perforin resistance, death ligands would contribute to NK cell-mediated cancer control. This evidence concerns the gene PRF1 and cancer.